🟢 Anixa Biosciences is trading 7.6% up in pre-market; no definitive catalyst identified

Anixa Biosciences is trading 7.6% up at $3.30, rebounding from the September 4, 2026 close of $3.07 after a prolonged decline.

• No definitive company-specific catalyst was identified for the September 8 pre-market move.
• Investors may be positioning ahead of the September 9 Nasdaq & LD Micro SF Summit presentation and upcoming third-quarter earnings expectations, but available coverage does not establish either event as the cause.
• The broader market is mixed to weaker, providing no clear macro explanation.